Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock
Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock
复制标题
DOI:
10.1097/shk.0b013e318033e5da
复制
发表时间:
2007-08-01
期刊:
影响因子:
3.1
通讯作者:
Christ-Crain, Mirjam
中科院分区:
文献类型:
--
作者:
Morgenthaler, Nils G.;Mueller, Beat;Christ-Crain, Mirjam
Arginine vasopressin (AVP) levels are increased in hemorrhagic and septic shock. Measurement of AVP levels has limitations due to its short half-life and cumbersome detection method. Copeptin is a more stable peptide derived from the same precursor molecule. We evaluated the plasma copeptin concentration in two independent studies: first, in an experimental baboon model of hemorrhagic shock, and second, in a prospective observational study of 101 consecutive critically ill patients at a university hospital. Copeptin was measured with a newly developed sandwich immunoassay using two polyclonal antibodies to the C-terminal region (amino acid sequence 132-164) of pre-pro-AVP. Copeptin concentrations in hemorrhagic shock increased markedly from median (range) of 7.5 [2.7-13) to 269 pM (241-456 pM). After reperfusion, copeptin levels dropped within hours to a plateau of 27 pM (15-78 pM). In the critically ill patient cohort, copeptin values increased significantly with the severity of the disease and were in patients without sepsis [27.6 pM [2.3-297 pM]), in sepsis [50.0 pM [8.5-268 pM]), in severe sepsis [73.6 pM [15.3-317 pM]), and in septic shock [171.5 pM (35.1-504 pM] compared with 4.1 pM (1.0-13.8 pM) in healthy controls (P for all vs. controls